Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041...

FDA Recall #D-0600-2021 — Class II — May 4, 2021

Recall #D-0600-2021 Date: May 4, 2021 Classification: Class II Status: Terminated

Product Description

Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877

Reason for Recall

Subpotent Drug

Recalling Firm

Boehringer Ingelheim Pharmaceuticals, Inc. — Ridgefield, CT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

15,198 bottles (30 tablets per bottle)

Distribution

AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR

Code Information

Lot #860412; SEPT 2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls